Delos Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $39K | Buy |
+210
| New | +$39K | 0.03% | 103 |
|
2025
Q1 | – | Sell |
-3
| Closed | -$611 | – | 54 |
|
2024
Q4 | $611 | Hold |
3
| – | – | ﹤0.01% | 185 |
|
2024
Q3 | $672 | Sell |
3
-83
| -97% | -$18.6K | ﹤0.01% | 164 |
|
2024
Q2 | $14.8K | Sell |
86
-8
| -9% | -$1.38K | 0.01% | 109 |
|
2024
Q1 | $17.2K | Buy |
94
+83
| +755% | +$15.2K | 0.02% | 98 |
|
2023
Q4 | $1.73K | Sell |
11
-424
| -97% | -$66.8K | ﹤0.01% | 141 |
|
2023
Q3 | $63.9K | Hold |
435
| – | – | 0.08% | 60 |
|
2023
Q2 | $58.6K | Hold |
435
| – | – | 0.07% | 62 |
|
2023
Q1 | $69.3K | Hold |
435
| – | – | 0.09% | 56 |
|
2022
Q4 | $70.3K | Hold |
435
| – | – | 0.11% | 53 |
|
2022
Q3 | $58K | Hold |
435
| – | – | 0.07% | 56 |
|
2022
Q2 | $67K | Buy |
435
+1
| +0.2% | +$154 | 0.07% | 52 |
|
2022
Q1 | $70K | Hold |
434
| – | – | 0.07% | 68 |
|
2021
Q4 | $59K | Buy |
434
+424
| +4,240% | +$57.6K | 0.06% | 69 |
|
2021
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 159 |
|
2021
Q2 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 152 |
|